Breadcrumb Navigation

Oncology Seminar Series – Spring/Summer 2021

We cordially invite you to the 2021 Oncology Seminar Series of the Comprehensive Cancer Center Zurich. The weekly seminar series brings together clinicians, scientists, caregivers and collaboration partners in the field of oncology. Invited speakers and CCCZ faculty present state-of-the-art knowledge and latest developments in cancer medicine and cancer research at Grand Rounds, scientific, clinical and educational lectures.

Standort

Online (via Zoom)

Credits

1 SGMO (except C3Z Joint Cancer Meetings)

This event regularly takes place on Mondays.

11.01.2021 17.00 - 18.00h Matthias Guckenberger
18.01.2021 17.00 - 18.00h Andreas Wicki
25.01.2021 17.00 - 18.00h Joint Cancer Meeting
01.02.2021 17.00 - 18.00h Maries van den Broek
08.02.2021 17.00 - 18.00h Thorsten Zenz
01.03.2021 17.00 - 18.00h Bernd Bodenmiller
08.03.2021 17.00 - 18.00h Panagiotis Balermpas
15.03.2021 17.00 - 18.00h Joint Cancer Meeting
22.03.2021 17.00 - 18.00h Alessandra Curioni
29.03.2021 17.00 - 18.00h Michael Krauthammer
12.04.2021 17.00 - 18.00h Steffen Böttcher
17.05.2021 17.00 - 18.00h Joint Cancer Meeting
31.05.2021 17.00 - 18.00h Andreas Wicki
07.06.2021 17.00 - 18.00h Ralph Fritsch
14.06.2021 17.00 - 18.00h Joint Cancer Meeting
21.06.2021 17.00 - 18.00h Wiebke Rösler
28.06.2021 17.00 - 18.00h David Blum
05.07.2021 17.00 - 18.00h Janine Reichenbach
12.07.2021 17.00 - 18.00h Anja Lorch

Important Information

  • No registration is required.
  • Zoom Meeting Link is provided before each meeting.

Program Details

11.1.2021 Highlights 2020 in Radiation Oncology – Matthias Guckenberger, Dep. of Radiation Oncology, USZ
18.1.2021 Highlights Medical Oncology 2020 – Andreas Wicki, Dep. of Medical Oncology and Hematology, USZ
25.1.2021 Joint Cancer Meeting: Patrick Roth – Dep. of Neurology, USZ // Achim Weber – Institute for Pathology and Mol.Pathology, USZ // Lukas Sommer – Institute of Anatomy, UZH
1.2.2021 Grand Round: CD39+PD-1+CD8+ T cells mediate metastatic dormancy in breast cancer –  Maries van den Broek, Institute of Experimental Immunology, UZH
8.2.2021 Update Neoplasia of the Lymphoid System – Thorsten Zenz, Dep. of Medical Oncology and Hematology, USZ
1.3.2021 Grand Round:  Multiscale analysis of in situ tumor biology towards precision medicine – Bernd Bodenmiller, Dep. of Quantitative Biomedicine, UZH
8.3.2021 Current Status of Combined Radiotherapy and Immunotherapy – Panagiotis Balermpas, Dep. of Radiation Oncology, USZ
15.3.2021 Joint Cancer Meeting: Roger Schibli – Dep. of Chemistry and Applied Biosciences, ETH // Michael Weller – Dep. of Neurology, USZ // Christian Stockmann – Institute of Anatomy, UZH
22.3.2021 Update Lung Cancer – Alessandra Curioni, Dep. of Medical Oncology and Hematology, USZ
29.3.3021 Grand Round: Title TBD – Michael Krauthammer, Dep. of Medical Informatics, USZ
12.4.2021 Update Clonal Hematopoiesis – Steffen Böttcher, Dep. of Medical Oncology and Hematology, USZ
17.5.2021 Joint Cancer Meeting: Alessandro Sartori – Institute of Molecular Cancer Research, UZH // Matthias Altmeyer – Dep. of Molecular Mechanisms of Disease, UZH // Beat Schäfer – University Childrens’ Hospital
31.5.2021 Grand Round: Prediction in Oncology – Andreas Wicki, Dep. of Medical Oncology and Hematology, USZ
7.6.2021 Update Gastrointestinal Cancer – Ralph Fritsch, Dep. of Medical Oncology and Hematology, USZ
14.6.2021 Joint Cancer Meeting: Sabine Werner – Institute for Molecular Health Sciences, ETH // Lynn Wong – Institute of Experimental Immunology, UZH // Isabelle Schmitt-Opitz – Department of Thoracic Surgery, USZ
21.6.2021 Update Histiocytosis – Wiebke Rösler, Dep. of Medical Oncology and Hematology, USZ
28.6.2021 Palliative Care in the Era of Personalized Medicine -David Blum, Competence Center Palliative Care, Dep. of Radiation Oncology, USZ
5.7.2021 Update Gene Therapy in Immunodeficiencies – Janine Reichenbach, Inst. of Regenerative Medicine, UZH
12.7.2021 Update Genito-urinary Cancer – Anja Lorch, Dep. of Medical Oncology and Hematology, USZ

This event is supported by: Astellas, Astra Zeneca, Bristol-Myers-Squibb, Daiichi Sankyo, Ipsen Pharma, Janssen-Cilag, Mepha Pharma, Merck, MSD, Novartis, PharmaMar, Pierre Fabre, Roche, Sanofi Genzyme, Servier

Contact

Silke Uflacker
C3Z Outreach and Event Manager

Tel. +41 79 378 81 77
Mail C3Z@usz.ch

Coordination

Matthias Guckenberger, Prof. Dr. med.

Klinikdirektor, Klinik für Radio-Onkologie
Stv. Leiter Prostatakarzinomzentrum, Comprehensive Cancer Center Zürich
Director C3Z Outreach and Education, Comprehensive Cancer Center Zürich

Spezialgebiete: Therapie des Lungen Karzinom, Therapie des Prostata Karzinom, Therapie von Oligometastasen
Tel. +41 44 255 29 30

Behandelnder Fachbereich

Comprehensive Cancer Center Zürich